Background {#Sec1}
==========

Iodine is an essential micronutrient necessary for the synthesis of thyroid hormones. It has long been recognized that foetal as well as obstetric outcomes are dependent on normal maternal thyroid function \[[@CR1]\]. Severe iodine deficiency during foetal development results in maternal and foetal hypothyroidism and is associated with serious adverse health effects, including mainly cretinism and prenatal as well as postnatal growth retardation \[[@CR1]\]. As confirmed many times, thyroid hormones are crucial for the correct development of the nervous system of the child \[[@CR2]\].

Physiologically, gestation calls for significant alterations in the functioning of the thyroid system, with increased maternal iodine requirements consequently reaching over 50% \[[@CR3], [@CR4]\]. This increase is associated with increasing foetal demand on thyroid hormones synthesized by the mother. While the foetus is capable of synthesizing its own thyroid hormones beginning with the 16th to 20th week of gestation, during the 8th to 10th week the foetus utilizes exclusively maternal hormones and is thus fully dependent on maternal synthesis at this very early gestation stage \[[@CR4]--[@CR6]\].

Human chorionic gonadotropin (hCG), a pregnancy-associated hormone, is involved in the stimulation of the thyrotropin receptor (TSH-receptor), resulting in the consequent increase in the level of the circulating hormone leading to suppressed TSH levels via negative feedback. In addition to hCG, factors directly influencing maternal thyroid function include i) increased renal iodine clearance, ii) estrogen-dependent increase in thyroxine-binding globulin and iii) placental deiodinase activity. The establishment of cut-off values for thyroid hormones in pregnancy/lactation therefore requires an approach which takes into account gestational age. Among the above mentioned factors, increasing iodine clearance is of considerable importance in pregnancy as renal plasma flow increases by 75% in mid-pregnancy and there is a 50% higher glomerular filtration rate (GFR) between the first and third trimesters \[[@CR7]\]. The increased renal clearance of iodine can therefore lead to relatively lower plasma inorganic iodide (PII) concentration, which in turn leads to higher sodium-iodide symporter activity in the thyroid. This situation could then lead to increased thyroid iodide clearance in order to compensate for the relative changes of plasmatic iodide and mainly to keep the absolute uptake of iodide within the same range \[[@CR7]\].

As iodine is deeply involved in the development and maintenance of a healthy pregnancy, pregnant women and their foetuses as well as infants are most vulnerable to its deficiency. However, there is no unanimous consensus on the issue of iodine supplementation in pregnancy. In 2007, the WHO/UNICEF/ICCIDD \[[@CR8]\] reached a limited consensus, stipulating that iodine-containing supplements should not be recommended to pregnant women if a given population has been iodine sufficient for at least two years. More specifically, if the population in general has an adequate iodine intake with the median urinary iodine concentration (UIC) ≥100 μg/l but lower than 150 μg/l, both the American Thyroid Association \[[@CR9]\] and the European Thyroid Association \[[@CR10]\] recommend supplementation. This approach, however, is not currently advocated by the WHO, which recommends an iodine intake of 250 μg/day during pregnancy, with salt iodization listed as the key strategy suitable for fighting possible deficiencies.

According to the WHO, the Czech Republic now ranks among countries where iodine deficiency is not considered a major public health issue. However, the Central European region has a long history of moderate to severe iodine deficiency. Salt iodisation was first introduced in Czechoslovakia (now the Czech Republic) in 1947, with a subsequent dramatic decrease in cases of severe iodine deficiency \[[@CR11]\]. Median urinary iodine values in general as well as in hospitalized adult populations shifted, with initial values indicating mild iodine deficiency (88--95 μl/l) prior to 1997, reaching a critical threshold of 100 μl/l in 1998 and achieving optimal values of 120--140 μl/l by 2000 \[[@CR11]\]. Between 1995 and 2016, urinary iodine concentration monitoring was conducted in various population groups, with the most recent study (2015) observing median urinary iodine concentrations in pregnant Czech women to be 151 μl/l while approximately 50% of studied women fulfilled criteria of iodine deficiency \[[@CR12]\].

While sufficient information on urine iodine levels is available, information on dietary iodine intake in the Czech Republic and its association with public health risk is very scarce. This study therefore aims to evaluate the estimated dietary iodine intake in pregnancy in a large prospective cohort from the European Longitudinal Study of Pregnancy and Childhood (ELSPAC), contextualize the achieved results with respect to dietary iodine and investigate the relationship between iodine intake and defined birth outcomes.

Methods {#Sec2}
=======

Study subjects {#Sec3}
--------------

ELSPAC is a population-based study designed to investigate environmental and other factors affecting the health and development of children from the prenatal period until adulthood \[[@CR13]\]. The study was initiated as one of six prospective birth cohort studies by the WHO Regional Office for Europe in 1985 and was designed to accommodate a total of 40,000 children across Europe \[[@CR14]\]. The project was initially coordinated by Bristol University (Avon Longitudinal Study of Pregnancy and Childhood; ALSPAC \[[@CR15]\]) and included eight independent centres based in the United Kingdom, Czechoslovakia, Ukraine, Greece and Russia. In the Czech part of the study, all eligible mothers were living in Brno or Znojmo (cities in Czechoslovakia) and were expected to deliver between 1 April 1991 and 30 June 1992. A total of 4711 participants who answered over 50% of the selected questions were included in the analyses. Approximately 9.7% of all answers were missing and were imputed, as described further. A total of 67 women who were on thyroid hormone replacement or anti-thyroid drugs or who reported thyroid disease were excluded from the study.

Ethics statement {#Sec4}
----------------

Ethical approval for the study was obtained from the European Longitudinal Study of Pregnancy and Childhood (ELSPAC) Law and Ethics committee and local research ethics committees. Written informed consent was obtained from all study participants and archived.

Dietary assessment {#Sec5}
------------------

Participating women were asked to answer two questionnaires during pregnancy, a questionnaire about themselves (P1 -- About You, Mother) and a questionnaire about their pregnancy (P2 -- I am Expecting a Baby). A self-reported food frequency questionnaire (FFQ) was included as part of the P2 questionnaire package in accordance with the ELSPAC protocol \[[@CR14]\] at 32 weeks of gestation in 1991--1992. Based on available domestic and foreign sources as well as on an expert assessment of portion sizes carried out by nutrition specialists, a list of individual food items associated with specific portion sizes which also reflected the composition of food items in the early 1990s was developed. The final questionnaire included 145 items in 36 separate food groups. The utilization of domestic sources allowed us to define portion sizes not only for global foods but also for local or regional foods, in accordance with an approach previously used e.g. by the HAPIEE study \[[@CR16]\]. Answers to a total of 44 questions from the P2 questionnaire were used to calculate iodine intake. The results of iodine content analysis for individual items and food groups are provided in Table [1](#Tab1){ref-type="table"}.Table 1Estimated iodine content in selected items/groupsList of food groupsFood itemIodine content \[μg/100 g or 100 ml\]Refined flour bakery productsbread4.0rollsFrench breadWhole-wheat bakery productsgraham bread4.0whole grain rollBreakfast cerealsoatmeal4.0puffed ricepopcornporridge11.0flavoured granolabran1.3grain sproutsKolaches, sweet rollssweet rolls4.9kolachescakessoufflésleavened cakessponge cakedoughnuts8.9dessertsomelettesBiscuits, wafers, sponge biscuitssponge biscuits13.5filled wafersPuddingsfruit-based14.1milk-basedfruit yoghurtwhipped cottage cheese productsPoultrychicken1.1ducksgooseRed meatbeef3.1porkmuttonhambaconPâtéspâtés7.5minced meatOffalliver11.9kidneyheartSausagessmoked meat7.8frankfurterssausagesother smoked meat productshamburgershamburger pattiesPizza6.5Fishcanned fish30.0fresh fish25.0frozen fishShellfishoysters116.0crabssnailsEggseggs50.0breakfast eggs50.0Cheesecheese7.0breakfast cheese7.0Legumesbaked beans4.0peas5.8lentilssoybeansbreakfast beans4.3breakfast soybeansNutsnuts5.8roasted nutssalted nutsFried potatoesFrench fries3.6Roasted potatoes9.0Boiled potatoesboiled potatoes9.3mashed potatoesPasta9.0Ricecooked rice3.0Leaf vegetablescabbage4.8kale (leaf cabbage)cauliflowerspinachleekgreen beansRoot vegetablescarrot7.9parsleycelerybeetSaladslettuce3.4cucumber saladtomato saladFresh fruitapples3.2pearsorangesbananasgrapesplumsFruit juices0.8ColaCola0.5PepsiTea except for herbal tea0.1Coffee0.5Herbal teas0.2Chocolatechocolate14.5confectioneryMilkmilk14.4dairy productsHoney2.0Soft drinkslemonade3.2soda

Food estimates were combined with iodine content data from national databases and reported as μg of iodine per 100 g or 100 ml. To achieve a precise and complete evaluation of iodine intake from all possible sources, the following databases were used in hierarchical order: Czech Food Composition Database \[[@CR17]\], Slovak Online Food Database \[[@CR18]\], National Food Composition Database in Finland \[[@CR19]\], Danish Food Composition Databank \[[@CR20]\], Composition of Foods Integrated Dataset (CoFID) \[[@CR21]\] and the Nutridan nutritional programme database \[[@CR22]\]. The consumption coefficient was derived from retrospective food consumption data based on databases from 1920 to 2006. The average portion was defined for all food item categories with respect to definitions in view of the fact that portion sizes have changed throughout the post-communist period, that weights and volumes of many foods have changed over time and that current sizes thus cannot be used. Generally, portion sizes were derived from two domestic sources from the 1990s: the Verbal and Graphic Formulation of Dietary Guidelines for the Czech Republic project \[[@CR23]\] and the Czech National Food Consumption Survey, implemented in the 2003--2006 period \[[@CR24]\]. A weighted average of portion sizes for the entire food group was then calculated based on the consumption ratio of individual foods.

Birth outcomes {#Sec6}
--------------

Selected birth outcomes were treated as dependent variables in the models: birth length and weight, placental weight and cephalisation and ponderal indices. Gestational age, gestational diabetes, gestational hypertension, stillbirth, congenital malformations, pre-eclampsia and IVF pregnancy were included as independent variables. All data were collected by healthcare professionals at the maternity hospital at the time of birth. Gestational age was determined using ultrasound dating.

Pre-eclampsia was defined in accordance with the International Society for the Study of Hypertension in Pregnancy (ISSHP) criteria \[[@CR25]\] as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg along with proteinuria of ≥1+ on urine dipstick testing occurring on two occasions after 20 weeks of gestation. Small for gestational age was defined as being below the 10th percentile of birth weight adjusted for gestational age at birth using internal standardisation by cohort. Preterm birth was defined as birth before 37 weeks of gestation. Gestational diabetes was defined as any record of a diagnosis of gestational diabetes at any time during the pregnancy in women without existing diabetes at the beginning of pregnancy.

Birth weight was measured to a precision of 0.1 kg. Placental weight was reported by the doctor present at birth. All possible gestational complications were summarised in the physician's birth questionnaire (N1). The ponderal index was calculated as birth weight (kg) divided by birth length cubed (m^3^). The cephalisation index was expressed as the ratio of head circumference at birth (cm × 10^4^) to birth weight (g) and later expressed as μm/g \[[@CR26]\].

Covariates {#Sec7}
----------

Several variables may be considered to constitute potential confounding factors for the investigated birth outcomes. In order to construct statistical models for defined birth outcomes, the following independent variables were included in the analyses, as appropriate: dichotomised comorbidities in present and previous pregnancies (gestational diabetes at present, pre-eclampsia, gestational hypertension associated with a current pregnancy, stillbirth occurring in the past, in vitro fertilization associated with a current pregnancy and congenital malformations in the past), gestational age, maternal pre-conceptional weight, maternal age at birth, maternal smoking prior to pregnancy (never smoker, smoker in the past, smoker in the last nine months), living with partner status (yes--no), self-reported alcohol intake during pregnancy and self-reported drug abuse during pregnancy. Maternal socioeconomic status, a variable generally associated with adverse birth outcomes, was assessed based on several variables: maternal education (categorized according to ISCED), maternal job (categorized according to ISCO 88 and ISCO 08 into 16 groups and 4 skill levels), ethnicity (Caucasian, other) and family income calculated according to Eurostat recommendations for equalized family income \[[@CR27]\], and appropriately adjusted to. Since extreme maternal height may sometimes be associated with an increased risk of adverse birth outcomes, all models were adjusted to also accommodate maternal height. Moreover, as advanced maternal age as well as offspring gender may be associated with worse obstetric outcomes, adjustments taking into account maternal age at birth as well as child gender were also made.

Statistical modelling {#Sec8}
---------------------

Dietary iodine intake was analysed using 44 food items with established iodine content selected from FFQs administered to study subjects. Uniformity was tested by examining the distribution of variables in a loading plot verified using the Kaiser-Meyer-Olkin (KMO) measurement of adequacy with a value of 0.5 considered as acceptable for further analysis. The Bartlett sphericity test was used to establish whether the correlation matrix differed significantly from the identity matrix \[[@CR28]\]. Orthogonal varimax rotation was used to minimize the number of indicators which might have high loading on one factor \[[@CR29]\].

The relationship between maternal dietary iodine intake and birth outcomes was investigated using linear regression models. Multivariate models were built for each birth outcome separately in two steps. First, the association between maternal dietary iodine intake and birth outcomes was investigated using a crude unadjusted analysis using the univariate models. Second, biological factors (maternal height, paternal height, maternal preconception weight and maternal age), social and demographic characteristics (maternal and paternal education, ethnicity, occupation, equalized family income), maternal health and comorbidities of the mother and child (gestational diabetes, gestational hypertension, stillbirth, child congenital malformations, IVF pregnancy and pre-eclampsia), maternal alcohol consumption, substance abuse, smoking and use of nutritional supplements during pregnancy, and finally gestational age and sex of the child were included as potential confounders into final (adjusted) multivariate models.

Missing data were imputed using the Multiple Imputation by Chained Equations method \[[@CR30]\] and regression models were built using imputed data. All analyses were performed using R, version 3.1.2 and STATA, version 14. *P*-values of less than 0.05 were considered statistically significant.

Results {#Sec9}
=======

Population characteristics {#Sec10}
--------------------------

The basic anthropometric and demographic characteristics of the study subjects are provided in Table [2](#Tab2){ref-type="table"}.Table 2Basic anthropometric/demographic characteristics of the study subjectsvariableunitmeansdmedian5th perc.95th perc.minmaxIodine intakeμg/day106.642.4101.149.2175.66.7612.5Family incomeCZK/month54902490500026009000150048,000Equalized family sizeperson2.20.62.11.83.31.010.5Equivalized family incomeCZK/month2596128624781071444436426,667Maternal agey25.24.824.618.834.715.248.7Gestational ageweek39.71.739.936.741.923.144.6Birth lengthcm50.22.350.046.053.030.059.0Birth weightg32904933300250040506005350Placental weightg5871645603808601151500Head circumferencecm34.61.435.032.037.023.043.0Cephalisation indexμm/g107.217.6104.787.7133.360.7500.0Ponderal indexkg/m^3^25.92.325.822.529.616.349.3Birth weight / Placental weight--5.91.65.83.78.91.517.3Maternal heightcm166.36.0167.0157.0176.0135.0189.0Paternal heightcm179.66.8180.0169.0191.0152.0204.0Maternal preconc. weightkg61.09.960.048.080.038.0135.0Maternal preconc. BMIkg/m^2^22.03.321.518.128.315.146.1Energy intakekJ/day655821576272356310,273250419,362FS Prudent--0.01.0−0.1−1.41.9−2.13.9FS Carbohydrates--0.01.0−0.1−1.51.8−3.13.5FS Junk food--0.01.0−0.1−1.51.8−2.83.7

Dietary patterns {#Sec11}
----------------

Food group analysis was performed using factor analysis. The adequacy of data for analysis was evaluated based on the KMO value \[[@CR31]\]; the result of Bartlett's sphericity test (χ^2^ = 14,435, df = 630, *p* \< 0.001) provided strong statistical evidence that the correlation matrix was significantly different from the identity matrix.

Three factors identified in pregnant women explained 14.6% of total variance. The first factor -- which accounted for 6.2% of total variance among mothers -- was labelled the prudent factor. This factor may be characterized by high factor loading in the case of whole-wheat bakery products, fish, legumes, fresh vegetables, root vegetables and rice. The second factor -- which accounted for 4.5% of total variance -- was labelled the carbohydrate--dairy factor and included foods such as refined flour bakery products, pudding, cheese, fresh fruit, milk and dairy products. The third factor -- which accounted for 3.9% of total variance -- was labelled the junk food factor and included items such as biscuits, wafers, pies and cakes, French fries, roasted potatoes, pâté and ground meat. The factors scores of the individual patterns have been reported in our previous paper focusing on the association of anthropometry with dietary patterns of mothers in the third trimester \[[@CR32]\].

Estimated iodine intake and birth outcomes {#Sec12}
------------------------------------------

In order to address the potential association between estimated iodine intake and placental size in the context of birth outcomes, we first performed an estimation of average dietary iodine intake by assigning average iodine intake to individual food items. Since no longitudinal comprehensive Czech database providing measured iodine levels for a broad spectrum of foods in the relevant period (1991--1992) is currently available, we derived iodine intake data from multiple available databases and systematically contextualized iodine content with individual FFQ items. As considerable differences in reported iodine intake between databases from various geographical regions were established, we based our methodology on the origin of iodine in foods in close geographical regions. For example, while the Czech Food Composition Database \[[@CR17]\] reported values of iodine content in fish to be 0--4.1 μg/100 g, the National Food Composition Database in Finland \[[@CR33]\] reported a value of 105 μg/100 g and the Danish Food Composition Databank \[[@CR34]\] reported a value of 253 μg/100 g. In such cases, we used values from the database from a geographical region closest to the Czech Republic. While the highest iodine content was reported for infant formula, powdered soups, smoked fish, canned meat and sausages, milk and saltwater fish, the most frequently consumed and thus most important dietary sources included milk, baked goods, eggs, saltwater fish, potatoes, pasta and yoghurt \[[@CR35]\]. The high dietary exposure to iodine from animal sources is the result of massive iodine supplementation of animal feed in the case of animals destined for meat and egg production, ongoing throughout the study period.

Once various birth outcomes included in the initial model were reduced to dependent variables, we obtained a single final model with a statistically significant relationship between estimated iodine intake and placental weight. We observed a negative association which indicates that every 100 μg of daily iodine intake during pregnancy is significantly associated with a 2.5% decrease in placental weight (95% CI: 0.6;4.3%).

Quartiles of cohort subjects with respect to estimated iodine intake are provided in Table [3](#Tab3){ref-type="table"}. Models for other outcomes including e.g. birth weight were non-significant and are not discussed further. The results of univariate as well as multivariate regression modelling for the logarithm of placental weight are provided in Table [4](#Tab4){ref-type="table"}. The table shows the estimated coefficients of linear regression in unadjusted (univariate) and fully adjusted (multivariate) models for the effects of maternal dietary iodine intake and other covariates on placental weight. Results with other birth outcomes as dependent variables are not shown as no significant associations with dietary iodine were observed. In the final model for the natural logarithm of placental weight, dietary estimated iodine intake was found to be a significant predictor of logarithm of placental weight (β = −0.025, 95% CI: -0.044; −0.006, *p* = 0.011).Table 3Quartiles of study subjects in relation to birth outcomes and estimated iodine intake (as mean ± sd)VariableEstimated iodine intake \[μg/day\]Q1\
(6.6; 79.7\]Q2\
(79.7; 101.0\]Q3\
(101.0; 127.5\]Q4\
(127.5; 612.5\]*P*- valueBirth length \[cm\]50.1 ± 2.350.2 ± 2.250.3 ± 2.350.1 ± 2.30.112Birth weight \[g\]3288 ± 4703287 ± 4703325 ± 493^a^3263 ± 501^a^0.035Placental weight \[g\]591 ± 168595 ± 167^a^587 ± 166576 ± 163^a^0.035Cephalisation index \[μm/g\]107.5 ± 20.1107.1 ± 16.4106.0 ± 16.8^a^108.0 ± 17.3^a^0.059Ponderal index \[kg/m^3^\]25.9 ± 2.225.9 ± 2.526.0 ± 2.325.8 ± 2.20.266Birth weight/Placental weight \[−\]5.9 ± 1.65.9 ± 1.66.0 ± 1.556.0 ± 1.60.083^a^significant differences between means in post-hoc analysis using Tukey-Kramer methodTable 4The effects of iodine intake and other covariates on natural logarithm of placental weight in univariate and multivariate modelsUnivariate modelsMultivariate modelβ estimate95% CI for β estimate*p*-valueβ estimate95% CI for β estimate*p*-valueIodine intake \[100 μg/day\]−0.032(−0.050; −0.013)\<0.001−0.025(−0.044; −0.006)0.011Gestational diabetes No(ref)(ref) Yes−0.088(−0.149; −0.027)0.005−0.080(−0.140; −0.020)0.009Pre-eclampsia No(ref)(ref) Yes−0.105(−0.208; −0.002)0.046−0.133(−0.234; −0.031)0.011Gestational hypertension No(ref)(ref) Yes0.062(0.010; 0.113)0.0190.053(0.001; 0.104)0.046Gestational age \[w\]0.015(0.010; 0.019)\<0.0010.013(0.009; 0.018)\<0.001Stillborn No(ref)(ref) Yes−0.064(−0.149; 0.022)0.143−0.056(−0.140; 0.028)0.193IVF pregnancy No(ref)(ref) Yes0.131(0.041; 0.220)0.0040.141(0.051; 0.230)0.002Congenital malformations No(ref)(ref) Yes0.016(−0.025; 0.057)0.4530.016(−0.025; 0.056)0.443Smoking Never(ref)(ref) Past smoker0.012(−0.005; 0.029)0.1520.008(−0.009; 0.025)0.353 Current smoker−0.024(−0.052; 0.005)0.100−0.019(−0.049; 0.011)0.206Substance abuse No(ref)(ref) Yes−0.050(−0.134; 0.034)0.239−0.033(−0.116; 0.051)0.443Alcohol No(ref)(ref) Yes−0.018(−0.048; 0.013)0.261−0.020(−0.050; 0.011)0.213Nutritional supplements No(ref)(ref) Yes0.050(0.035; 0.066)\<0.0010.047(0.031; 0.063)\<0.001ISCO skill level - mother Skill level 1(ref)(ref) Skill level 20.005(−0.031; 0.040)0.8050.001(−0.036; 0.037)0.978 Skill level 3−0.009(−0.048; 0.030)0.639−0.015(−0.056; 0.027)0.493 Skill level 4−0.006(−0.043; 0.031)0.741−0.014(−0.055; 0.027)0.506 Skill level unassigned−0.051(−0.176; 0.075)0.428−0.056(−0.179; 0.068)0.377ISCO skill level - father Skill level 1(ref)(ref) Skill level 2−0.006(−0.059; 0.046)0.814−0.007(−0.059; 0.044)0.783 Skill level 3−0.026(−0.083; 0.031)0.369−0.019(−0.076; 0.038)0.508 Skill level 4−0.013(−0.066; 0.041)0.6410.010(−0.046; 0.065)0.734 Skill level unassigned0.004(−0.056; 0.064)0.8940.026(−0.033; 0.085)0.386Education -- mother Basic(ref)(ref) Secondary0.005(−0.012; 0.023)0.5290.022(0.002; 0.043)0.035 University and higher0.000(−0.021; 0.022)0.9770.033(0.001; 0.065)0.043Education -- father Basic(ref)(ref) Secondary−0.001(−0.021; 0.018)0.880−0.001(−0.023; 0.021)0.936 University and higher−0.016(−0.035; 0.003)0.090−0.025(−0.054; 0.004)0.091Equalized family intake \[1000 CZK/month\]−0.002(−0.011; 0.008)0.698−0.002(−0.012; 0.009)0.732Age - mother \[y\]0.001(−0.001; 0.002)0.3770.000(−0.001; 0.002)0.669Height - mother \[cm\]0.002(0.000; 0.003)0.0120.002(0.000; 0.003)0.014Height - father \[cm\]0.000(−0.001; 0.001)0.9730.000(−0.002; 0.001)0.501Maternal preconceptional BMI \[kg/m^2^\]0.008(0.006; 0.010)\<0.0010.007(0.005; 0.010)\<0.001Ethnicity -- mother European(ref)(ref) Others−0.029(−0.100; 0.042)0.4290.020(−0.063; 0.104)0.632Ethnicity -- father European(ref)(ref) Others−0.039(−0.094; 0.016)0.168−0.018(−0.083; 0.047)0.591Sex of the child Girl(ref)(ref) Boy0.029(0.014; 0.045)\<0.0010.029(0.014; 0.045)\<0.001

Estimated iodine intake and birth weight / placental weight ratio {#Sec13}
-----------------------------------------------------------------

The results of univariate as well as multivariate regression modelling for the logarithm of birth weight / placental weight ratio are provided in Table [5](#Tab5){ref-type="table"}.Table 5The effects of iodine intake and other covariates on natural logarithm of birth weight/placental weight ratio in univariate and multivariate modelsUnivariate modelsMultivariate modelβ estimate95% CI for β estimate*p*-valueβ estimate95% CI for β estimate*p*-valueIodine intake \[100 μg/day\]0.015(−0.005; 0.035)0.1360.024(0.004; 0.043)0.016Gestational diabetes No(ref)(ref) Yes0.093(0.030; 0.156)0.0040.106(0.045; 0.167)\<0.001Pre-eclampsia No(ref)(ref) Yes0.008(−0.100; 0.116)0.8830.039(−0.065; 0.143)0.460Gestational hypertension No(ref)(ref) Yes−0.099(−0.153; −0.045)\<0.001−0.085(−0.138; −0.032)0.002Gestational age \[w\]0.042(0.037; 0.046)\<0.0010.041(0.036; 0.046)\<0.001Stillborn No(ref)(ref) Yes−0.008(−0.097; 0.081)0.8600.008(−0.076; 0.092)0.848IVF pregnancy No(ref)(ref) Yes−0.116(−0.210; −0.023)0.015−0.126(−0.216; −0.037)0.006Congenital malformations No(ref)(ref) Yes−0.029(−0.071; 0.013)0.179−0.035(−0.075; 0.006)0.095Smoking Never(ref)(ref) Past smoker−0.012(−0.029; 0.005)0.178−0.012(−0.029; 0.005)0.172 Current smoker−0.031(−0.060; −0.002)0.039−0.019(−0.049; 0.011)0.215Substance abuse No(ref)(ref) Yes−0.029(−0.113; 0.056)0.5010.000(−0.083; 0.083)0.998Alcohol No(ref)(ref) Yes0.015(−0.018; 0.048)0.3720.016(−0.015; 0.046)0.317Nutritional supplements No(ref)(ref) Yes−0.050(−0.066; −0.034)\<0.001−0.045(−0.061; −0.028)\<0.001ISCO skill level - mother Skill level 1(ref)(ref) Skill level 20.009(−0.028; 0.047)0.6340.006(−0.031; 0.042)0.764 Skill level 30.029(−0.011; 0.070)0.1600.016(−0.026; 0.058)0.444 Skill level 40.039(0.000; 0.078)0.0470.019(−0.022; 0.061)0.364 Skill level unassigned0.018(−0.111; 0.147)0.7860.031(−0.093; 0.155)0.621ISCO skill level - father Skill level 1(ref)(ref) Skill level 20.021(−0.034; 0.076)0.4490.010(−0.043; 0.063)0.709 Skill level 30.037(−0.023; 0.097)0.2250.007(−0.052; 0.067)0.816 Skill level 40.039(−0.016; 0.095)0.162−0.012(−0.069; 0.045)0.688 Skill level unassigned−0.027(−0.088; 0.033)0.378−0.038(−0.097; 0.021)0.206Education -- mother Basic(ref)(ref) Secondary0.013(−0.005; 0.030)0.164−0.019(−0.040; 0.002)0.081 University and higher0.030(0.008; 0.053)0.009−0.029(−0.062; 0.004)0.081Education -- father Basic(ref)(ref) Secondary0.017(−0.003; 0.037)0.0920.009(−0.014; 0.031)0.444 University and higher0.036(0.016; 0.055)\<0.0010.030(0.000; 0.060)0.047Equalized family intake \[1000 CZK/month\]0.009(−0.001; 0.019)0.0800.005(−0.006; 0.016)0.382Age - mother \[y\]0.002(0.000; 0.003)0.0480.001(−0.001; 0.003)0.463Height - mother \[cm\]0.003(0.002; 0.004)\<0.0010.001(0.000; 0.003)0.059Height - father \[cm\]0.002(0.001; 0.004)\<0.0010.001(0.000; 0.003)0.028Maternal preconceptional BMI \[kg/m^2^\]−0.001(−0.004; 0.001)0.238−0.001(−0.004; 0.001)0.345Ethnicity -- mother European(ref)(ref) Others−0.075(−0.150; −0.001)0.048−0.012(−0.098; 0.073)0.780Ethnicity -- father European(ref)(ref) Others−0.037(−0.094; 0.020)0.2040.011(−0.054; 0.075)0.740Sex of the child Girl(ref)(ref) Boy0.016(0.000; 0.032)0.0510.014(−0.001; 0.029)0.076

Discussion {#Sec14}
==========

Multiple physiological changes in thyroid function take place during pregnancy; aberrant thyroid function during pregnancy has been associated with adverse obstetric outcomes \[[@CR36]\]. Since the adverse impact of thyroid dysfunction on foetal development and obstetric outcomes has been empirically observed for decades, the issue of whether to screen for maternal thyroid dysfunction antenatally or preconceptionally or not is subject to an ongoing debate which has yet to be resolved in a satisfactory way. Furthermore, supplementation guidelines are also being debated worldwide. However, insufficient information is currently available on the role of iodine dietary intake on birth outcomes and subsequent child development, especially as most studies focus on the effects of supplementation and not on modified dietary composition. Exceptions include studies by Bath et al. \[[@CR37]\], Hynes et al. \[[@CR38]\] and Abel et al. \[[@CR39]\], which report that even a mild degree of iodine deficiency in pregnancy is associated with verbal IQ, reading accuracy and reading comprehension at 8 years \[[@CR37]\], educational outcomes at 9 years \[[@CR38]\] and child language delay, behavioural problems and reduced fine motor skills at 3 years of age \[[@CR39]\].

Based on our results, iodine intake may potentially change the weight of the placenta or the birth weight / placental weight ratio by several percent. This supports a hypothesis which states that the placenta may serve to some extent as an iodine reservoir capable of expanding in size to increase its absorption potential in the case of lower dietary iodine intake, i.e. in a manner similar to the thyroid gland. The same association of iodine intake and placental size has been observed in mice \[[@CR40]\]. Based on empirical observations of the detrimental effects of inadequate or excessive dietary iodine intake during pregnancy for foetal development and/or birth outcomes both for the mother and the child, it can be speculated that only a narrow range of optimum iodine levels leads to optimum outcomes. An existing animal study has reported the linear association of increasing toxicity with increasing dietary iodine intake and the association of decreasing placenta size with the linear growth of dietary iodine \[[@CR40]\], which thus supports the hypothesis that maternal thyroid hormones are directly involved in placental growth and development control.

The above mentioned findings are in line with the current understanding of the role of the trophoblast in the regulation of iodine and thyroid hormone transfer from the mother to the foetus. While the foetal thyroid starts to concentrate iodine after the first 10--12 weeks of gestation, the synthesis and secretion of the thyroid hormone under TSH control starts at approximately 20 weeks of gestation \[[@CR41]\]. Prior to the beginning of the autonomous synthesis of thyroid hormones, the foetus fully relies on maternal thyroxine and utilizes both T3 and T4 to stimulate EGF production by primary cytotrophoblasts, thus promoting their survival \[[@CR42]\]. Transplacental transport of maternal thyroid hormones is supported by the evidence of biologically significant concentrations of free thyroxine (t4) in foetal coelomic fluid, while these concentrations are highly independent on the thyroid of the offspring (in foetuses with absent thyroid, up to 50% of normal concentrations of t4 can be observed) \[[@CR43]\].

The transplacental passage of thyroid hormones from mother to foetus and the following supply of the thyroid hormones into trophoblast cells requires the expression of placental plasma membrane transporters for thyroid hormones. The human placenta displays a wide range of transporters for thyroid hormones from early gestation: MCT8, MCT10, LAT1, LAT2, OATP1A2 and OATP4A1; the observed expression patterns are different between pregnancies with normal physiology and pregnancies affected with intrauterine growth restriction \[[@CR44]\]. These transporters have been recently shown to accumulate iodine in the placental cell lines and are generally upregulated by hCG \[[@CR44]\].

The delivery of the maternal thyroid hormones to the foetus therefore depends on i) the availability of the thyroid hormones in the maternal circulation and ii) the functional effectiveness of the transplacental transport systems. Current knowledge of thyroid hormone transporters not only strongly suggests that the placenta plays a role in iodine uptake, but also supports the hypothesis that the placenta may act as a storage capacity supplying iodine to the foetus gradually \[[@CR45]\]. This is supported by recently established evidence which indicates that placental iodine uptake is saturable, which is typical of the thyroid gland \[[@CR46]\]. To conclude, while the thyroid has a demonstrably greater capacity for iodide update than the placenta, the placenta and thyroid appear to share numerous iodine uptake and efflux mechanisms \[[@CR45]\].

The exact mechanism and reason for decreasing placental size with increasing dietary iodine is, however, unknown and deserves further investigation. Although the importance of aberrant placental size is generally unclear, some evidence indicates that placental size may be associated with future developmental/cardiometabolic conditions. Some studies suggest that placental size is correlated with birth weight as well as with placental function \[[@CR47]\]. Under certain conditions, e.g. malnutrition, the placental surface may increase in order to obtain more nutrients for the foetus, which may in turn result in increased placental weight at birth \[[@CR48], [@CR49]\]. On the whole, while a small placenta has previously been associated with premature birth risk, increased placental size has been associated with an increased rate of adverse conditions in newborns \[[@CR50]\]. Some studies also associate placental size and weight with cardiometabolic risks later in life, e.g. with the risk of hypertension \[[@CR51]\] or with total bone mass \[[@CR52]\]. The association of placental size with bone mass and density is of special interest, as it was identified in ALSPAC, the mirror cohort to ELSPAC. However, any interpretation of such results between various ethnic groups and populations is complicated \[[@CR53]\] and requires further investigation.

The gold standard for the estimation of iodine status in the general population today is urinary iodine concentration measurement \[[@CR54]\]. Studies focusing on the association of urinary iodine concentration and dietary iodine intake are scarce and generally conclude that women with smaller placental size are more frequently prone to iodine deficiency \[[@CR55]\]. A 2011 study comparing Irish and Iranian women, however, established differences between these two populations with respect to the ratio of placental iodine and urinary iodine concentration \[[@CR46]\]. Based on this observation, it could be hypothesized that the placenta may act as a thus far unrecognized iodine reservoir designed to ensure the physiological development of the foetus despite fluctuations in dietary iodine.

At the time of data collection, recommended daily iodine intake was generally 50--100 μg/day with 150 μg/day recommended for pregnant women \[[@CR56]\]. The recommendation substantially changed over time, with recommended daily intake established at 150 μg/day for the non-pregnant population and 250 μg/day for pregnant or breastfeeding women. While recommended daily iodine intake for the non-pregnant population can be achieved quite easily, most pregnant/breastfeeding women are unable to achieve the recommended levels of iodine in their diet \[[@CR11]\]. In this study, we report that estimated iodine intake levels in pregnant women are below the recommended levels both for the early 1990s as well as for 2016, i.e. in line with previous observations conducted on smaller population samples. In a very recent study using the same Central European population, urinary iodine values of over 150 μg/l, i.e. complying with WHO requirements for pregnant women, were only found in 30% of the total of 750 examined Czech pregnant women \[[@CR57]\] with the median urinary iodine concentration above 151 μg/l. This implies that no significant improvement in supplementation has taken place over time (our results originating in the early 1990s are in line with very recent observations). Based on our results, the proper management of latent iodine deficiency seems to constitute a major public health issue in the Czech Republic.

Strengths and limitations {#Sec15}
-------------------------

The major limitation of the study is that due to the design of the study (no biological samples were available for this cohort) we were unable to carry out adjustments for urinary iodine. Due to the large number of subjects, it was necessary to use food frequency questionnaires which were not formally calibrated against diet diaries or biomarkers, i.e. a common approach in the early 1990s. Since the FFQ constitutes a methodological instrument designed to measure long-term dietary behaviour, it is prone to several methodological limitations, including a finite list of foods and food groups \[[@CR58]\]. Finally, it is possible that due to the retrospective nature of the questionnaire, some memory bias was introduced when compared with a prospective food records-based methodology.

On the other hand, it must be mentioned that this study is the first to investigate dietary iodine intake in relation to the dietary patterns of pregnant women in the transitional period of the early 1990s in Czechoslovakia. Moreover, it also provides insight into the significant relationship between dietary estimated iodine intake and defined adverse birth outcomes. Additional key points of this study include the relatively large sample size of pregnant women and multiple adjustment for confounding factors, although the possibility of residual confounding can never be entirely ruled out. In addition, the observed dietary patterns are consistent with patterns expected in early 1990s Czechoslovakia, which may be demonstrated e.g. by the absence of typical "imported" patterns such as Mediterranean and vegetarian diets not typical at the time.

Conclusion {#Sec16}
==========

This study reveals the possible influence of dietary iodine intake and its effect on placenta size, which influences the dynamics of intrauterine growth. These results contribute to the much-needed debate on iodine intake during the vulnerable child development period. Following adjustment for multiple confounders, including socio-economic status, our study found placental weight to be the only birth outcome significantly associated with iodine intake. While our research indicates that the placenta may be partially capable of compensating for iodine deficiency, more research into mechanistic relationship between iodine accumulation and placental growth is necessary. Based on our results, however, we encourage researchers to use placental weight as a possible interaction parameter with iodine supplementation in future studies.
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